Lexicon Pharmaceuticals | LXRX - Créances Commerciales





Créances Commerciales Changement Date
Abbott USD 11.22B 655M 2026-03
Acadia Pharmaceuticals USD 148.38M 153K 2026-03
Agios Pharmaceuticals USD 16.13M 5.56M 2026-03
Akebia Therapeutics USD 47.03M 19.19M 2025-12
Alnylam Pharmaceuticals USD 912.74M 28.78M 2026-06
AstraZeneca USD 18.86B 972M 2026-06
BioMarin Pharmaceutical USD 903.91M 4.3M 2026-03
Coherus Biosciences USD 18.42M 232.08M 2025-12
Eli Lilly USD 21.18B 1.02B 2026-03
Halozyme Therapeutics USD 457.99M 16.72M 2026-03
Illumina USD 764M 26M 2026-06
Insmed USD 178.55M 37.7M 2026-03
Ironwood Pharmaceuticals USD 81.89M 5.68M 2024-12
J&J USD 22.54B 1.21B 2026-03
Lexicon Pharmaceuticals USD 2.38M 50K 2025-12
MacroGenics USD 10.42M 2.95M 2026-03
MannKind USD 28.14M 10.23M 2026-03
Merck USD 11.78B 345M 2025-12
Moderna USD 17M 54M 2026-06
Novartis USD 9.85B 252M 2026-06
PTC Therapeutics USD 219.92M 38.3M 2026-03
Puma Biotechnology USD 28.1M 3.52M 2024-06
Sarepta Therapeutics USD 547.91M 149.68M 2026-03
Thermo Fisher Scientific USD 9.45B 247M 2026-06
Ultragenyx Pharmaceutical USD 60M 98M 2026-03
United Therapeutics USD 312M 38.2M 2026-03
Vanda Pharmaceuticals USD 47.1M 4.35M 2024-12